Paper Review Records
All Paper Review Records
6 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
20
days
Frailty and Rheumatoid Arthritis: Key Insights and the Road Ahead
Authors
Alexandra C. Legge; Grace Burns; Courtney N. Loecker; Devyani Misra; Katherine D. WyshamShow moreShow less
Affiliations
1. Dalhousie University; 2. Queen Elizabeth II Health Sciences Centre; 3. University of Nebraska Medical Center; 4. Beth Israel Deaconess Medical Center; 5. Harvard University; 6. University of Washington; 7. VA Puget Sound Health Care SystemShow moreShow less
43
days
Juvenile-onset Systemic Lupus Erythematosus: Recent Advances in Pathogenesis and Treatment
Authors
Valentina Natoli; Amandine Charras; Eve MD Smith; Christian M. HedrichShow moreShow less
Affiliations
1. Department of Women’s and Children’s Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK; 2. Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili, Università degli Studi di Genova, Genoa, Italy; 3. Rheumatology and Autoinflammatory Diseases Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy; 4. School of Infection & Immunity, University of Glasgow, Glasgow, UK; 5. Department of Paediatric Rheumatology, Alder Hey Children’s NHS Foundation Trust Hospital, Liverpool, UKShow moreShow less
166
days
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains
Authors
Medha Barbhaiya; Stephane Zuily; Mary-Carmen Amigo; Tadej Avcin; Maria Laura Bertolaccini; D. Ware Branch; Guilherme Ramires de Jesus; Katrien M. J. Devreese; Camille Frances; David Garcia; Francis Guillemin; Steven R. Levine; Roger A. Levy; Michael D. Lockshin; Thomas L. Ortel; Surya V. Seshan; Maria G. Tektonidou; Denis Wahl; Rohan Willis; Allison Hendry; Ray Naden; Karen H. Costenbader; Doruk ErkanShow moreShow less
Affiliations
1. Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery; Weill Cornell Medicine, New York, USA; 2. Vascular Medicine Department and Reference Center for Rare Systemic Autoimmune and Autoinflammatory Diseases, CHRU-Nancy, Nancy University Hospital; INSERM UMR-S 1116, University of Lorraine, Nancy, France; 3. Service of Rheumatology, ABC Medical Center, Mexico, Mexico; 4. Department of Allergology, Rheumatology, and Clinical Immunology, Children’s Hospital, University Medical Center, University of Ljubljana, Ljubljana, Slovenia; 5. Academic Department of Vascular Surgery, Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, King’s College London British, London, UK; 6. Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, USA; 7. Department of Obstetrics, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil; 8. Coagulation Laboratory, Department of Laboratory Medicine, Department of Diagnostic Sciences, Ghent University Hospital, Ghent University, Ghent, Belgium; 9. Department of Dermatology-Allergology, Tenon Hospital, Paris, France; 10. Department of Hematology, University of Washington, Seattle, USA; 11. CIC Clinical Epidemiology, CHRU, Inserm, Université de Lorraine, and INSPIIRE, Université de Lorraine, Inserm, Nancy, France; 12. Downstate Stroke Center and Department of Neurology, State University of New York Downstate Health Sciences University; Kings County Hospital Center, and Maimonides Medical Center/Jaffe Stroke Center, Brooklyn, USA; 13. Department of Rheumatology, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil; 14. Glaxo Smith Kline, Upper Providence, USA; 15. Department of Hematology, Duke University Medical Center, Durham, USA; 16. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, USA; 17. First Department of Propaedeutic Internal Medicine, National and Kapodistrian, University of Athens, Athens, Greece; 18. Antiphospholipid Standardization Laboratory, University of Texas Medical Branch, Galveston, USA; 19. Department of Medicine and Rheumatology, Middlemore Hospital, Auckland, New Zealand; 20. Department of Obstetric Medicine, Auckland City Hospital, Auckland, New Zealand; 21. Department of Rheumatology, Brigham and Women’s Hospital, Boston, USAShow moreShow less
87
days
The Role of FDG-PET in the Diagnosis and Monitoring of Large-Vessel Vasculitis
Authors
Alessandro Tomelleri; Corrado Campochiaro; Peter C. Grayson; Kaitlin A. QuinnShow moreShow less
Affiliations
1. Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; 2. National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, USAShow moreShow less
70
days
Advancing Juvenile Spondyloarthritis: Closing Knowledge Gaps with New Axial JSpA Classification Criteria
Authors
Brittney N. Newby; Pamela F. WeissShow moreShow less
Affiliations
1. Division of Pediatric Rheumatology, Children’s Hospital of Philadelphia, Philadelphia, USA; 2. Department of Pediatrics, Division of Rheumatology and Clinical Futures, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, USA; 3. Roberts Center for Pediatric Research, CHOP, Philadelphia, USAShow moreShow less
67
days
Updates on the Role of DXA in the Evaluation and Monitoring of Osteoporosis
Authors
Shahane Anupama; Sian Yik Lim; Marcy B. BolsterShow moreShow less
Affiliations
1. Division of Rheumatology, University of Pennsylvania, Philadelphia, USA; 2. Hawaii Pacific Health Medical Group, Honolulu, USA; 3. John E Burns School of Medicine University of Hawaii, Honolulu, US; 4. Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital , Boston, US; 5. Harvard Medical School, Boston, USAShow moreShow less
FAQ
How long does Current Rheumatology Reports take to review a manuscript?
As of 2026-11-19, CrushSCI has 6 complete review records for Current Rheumatology Reports. The fastest paper went from submission to acceptance in 20 days (Frailty and Rheumatoid Arthritis: Key Insights and the Road Ahead, received 2026-09-15, accepted 2026-10-05); the slowest took 166 days. The average is 75.5 days and the median is 68.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
